| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3025301 | Seminars in Thoracic and Cardiovascular Surgery | 2009 | 6 Pages |
Abstract
Malignant pleural mesothelioma is an aggressive malignancy for which surgical treatment is an option for a subset of patients. A gene ratio test based on the relative expression levels of four genes has been validated in clinical trials to predict which patients will benefit from surgical therapy. A description of the test properties and the independent predictors for outcome are provided.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raphael MD,